Clinical drug trials may not be focusing enough on safety and efficacy in children, according to research out of Boston Children's Hospital.
Boston Children's Hospital researchers surveyed studies registered in ClinicalTrials.gov, a database of federally and privately supported clinical trials conducted around the world. The team focused on drug trials from 2006 to 2011 for the 10 highest burden conditions as listed in the World Health Organization's Global Burden of Disease study.
The researchers found that while children bear nearly 60 percent of the burden of 10 major global diseases, only about 12 percent of the clinical trials for those diseases include or focus on children. The researchers believe funding may contribute to the lack of focus on children in these clinical trials.
Boston Children's Hospital researchers surveyed studies registered in ClinicalTrials.gov, a database of federally and privately supported clinical trials conducted around the world. The team focused on drug trials from 2006 to 2011 for the 10 highest burden conditions as listed in the World Health Organization's Global Burden of Disease study.
The researchers found that while children bear nearly 60 percent of the burden of 10 major global diseases, only about 12 percent of the clinical trials for those diseases include or focus on children. The researchers believe funding may contribute to the lack of focus on children in these clinical trials.
More Articles on Quality:
Dr. Stuart Levin Named VP of Quality for Blue Shield of California
Hospital Readmissions More Than Double the Cost of Care for Medicare Patients
White House Event Focuses on Improving Environmental Sustainability of Hospitals